IM-1021 Clinical Trial

Tag: IM-1021 Clinical Trial

March 28, 2025 • Views: 22

Immunome Announces Dosing of the First Patient in the Phase 1 Clinical Trial Testing IM-1021.

We’re here for everyone who is affected by cancer. We help people find reliable answers to questions about their disease, support, and life beyond cancer.

Let's Work Together

Partner With Us
Share Your Story
Become a Contributor

Site Map

Home
Articles
Community
Our Mission

Sign up for our weekly summary of articles and conversation.

↑

Hijacked by Scanxiety: How testing can take your peace February 27, 2025
Rare Black History: A Childhood Home of Rare Disease… August 31, 2023
Virginia’s Rare Cancer Journey: Extramammary… February 7, 2025
Study of the Week: New Method for Personalizing Head… April 17, 2023
Mantle Cell Lymphoma: Not Yet Curable, But This… March 1, 2023

Tag: IM-1021 Clinical Trial

Immunome Announces Dosing of the First Patient in the Phase 1 Clinical Trial Testing IM-1021.

Let's Work Together

Site Map

Sign up for our weekly summary of articles and conversation.

Popular Posts